StockClub

VNDA

VNDAVanda Pharmaceuticals Inc.$ --
Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

VNDA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
57M USD
YoY +7.6%
Operating Income
-40M USD
YoY -292.6%
Net Income
-141M USD
YoY -2774.3%
EPS
-2.39$
YoY -2728.4%

Revenue

$216.1M
FY2024 Q1$47.5M
$47.5M
Q1
FY2024 Q2$97.9M
$97.9M
Q2
FY2024 Q3$145.6M
$145.6M
Q3
FY2024 Q4$198.8M
$198.8M
Q4
FY2025 Q1$50M
$50M
Q1
FY2025 Q2$102.6M
$102.6M
Q2
FY2025 Q3$158.9M
$158.9M
Q3
FY2025 Q4$216.1M
$216.1M
Q4
Actual
+$17.3M (+8.7%)

Net Income

$-220.5M
FY2024 Q1$-4.1M
$-4.1M
Q1
FY2024 Q2$-8.7M
$-8.7M
Q2
FY2024 Q3$-14M
$-14M
Q3
FY2024 Q4$-18.9M
$-18.9M
Q4
FY2025 Q1$-29.5M
$-29.5M
Q1
FY2025 Q2$-56.7M
$-56.7M
Q2
FY2025 Q3$-79.3M
$-79.3M
Q3
FY2025 Q4$-220.5M
$-220.5M
Q4
Actual
$-201.6M (-1066.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$248.2M
Est:$244.5M
FY2020BEAT
$248.2M
FY2021MISS
Actual:$268.7M
Est:$270.7M
FY2021MISS
$268.7M
FY2022MISS
Actual:$254.4M
Est:$257.5M
FY2022MISS
$254.4M
FY2023BEAT
Actual:$192.6M
Est:$182M
FY2023BEAT
$192.6M
FY2024MISS
Actual:$198.8M
Est:$199.4M
FY2024MISS
$198.8M
FY2025MISS
Actual:$216.1M
Est:$218.3M
FY2025MISS
$216.1M

Analyst Estimates